SEC ownership of Cellebrite DI Ltd.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001854587.

Comparable stake leader

SUNCORPORATION

Disclosed value leader

SUNCORPORATION

Comparable rows

50/50

Latest evidence

21 May 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
SUNCORPORATION
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
21 May 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001854587
Issuer location
Petah Tikva, Israel

Ownership snapshot

Top shareholders of Cellebrite DI Ltd. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SUNCORPORATION
Disclosed value leader
SUNCORPORATION
Comparable rows
50/50
Latest evidence
21 May 2026
13D/G 13F 3/4/5 Lead comparable stake: 43% 13D/G row: SUNCORPORATION Showing 1-8 of 50 holder rows.

Quick read

SUNCORPORATION leads the comparable SEC ownership view at 43%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SUNCORPORATION's linked filing trail.
Comparable ownership Top 5
SUNCORPORATION 43%
TWC Tech Holdings II, LLC 6.1%
FMR LLC 4.1%
Adam H. Clammer 5.9%
Thomas E. Hogan 0.28%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SUNCORPORATION
13D/G
43%
$1,915,539,751
106,065,324 shares
+$63,014,988 31 Dec 2025
TWC Tech Holdings II, LLC
13D/G
Adam H. Clammer
6.1%
$294,700,753
14,661,729 shares
$0 18 Mar 2025
FMR LLC
13D/G 13F
Company
4.1%
$199,496,862
9,925,217 shares
-$13,992,153 31 Mar 2025
Adam H. Clammer
3/4/5
Director, Chair of the Board
5.9%
$201,442,569
14,682,403 shares
18 Mar 2026
Thomas E. Hogan
3/4/5
Chief Executive Officer, Director
0.28%
$9,521,199
693,965 shares
18 Mar 2026
Christopher Michael Wade
3/4/5
Chief Technology Officer
0.25%
$8,375,415
610,453 shares
18 Mar 2026
Marcus Jewell
3/4/5
Global Chief Revenue Officer
0.18%
$5,620,573
440,101 shares
-$166,639 18 May 2026
Shiven Ramji
3/4/5
President Products & Tech
0.17%
$5,836,519
423,550 shares
12 May 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$244,083.

Buys
$0
Insiders: 0
Sells
$244,083
Insiders: 2
Net
-$244,083
Shares: -18,942
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 18,942
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 18,942 $0 $244,083 -$244,083
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to Cellebrite DI Ltd.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Adam H. Clammer
Net 12M change
-$244,082
Latest report
21 May 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Adam H. Clammer Director, Chair of the Board $201,442,569 Mixed 18 Mar 2026
Thomas E. Hogan Chief Executive Officer, Director $9,521,199 Mixed 18 Mar 2026
Christopher Michael Wade Chief Technology Officer $8,375,415 Mixed 18 Mar 2026
Shiven Ramji President Products & Tech $5,836,519 Median 12 May 2026
Marcus Jewell Global Chief Revenue Officer $5,620,573 -$166,639 -2.9% Filing P/S 18 May 2026
David Barter Chief Financial Officer & Chief Accounting Officer $5,158,075 Mixed 18 Mar 2026
Ronnen Armon Chief Products & Technologies Officer $3,812,019 Mixed 18 Mar 2026
David Nicholas Gee Chief Marketing Officer $1,867,266 -$77,443 -4% Filing P/S 21 May 2026
Zohar Tadmor-Eilat Chief People Officer $1,781,048 Mixed 18 Mar 2026
Holly B. Windham General Counsel & Chief Compliance Officer $1,307,900 Mixed 18 Mar 2026
Sigalit Shavit Chief Information Officer $1,135,165 Mixed 18 Mar 2026
Yonatan Domnitz Director $834,107 Mixed 18 Mar 2026
Ryusuke Utsumi Director $559,707 Mixed 18 Mar 2026
Brandon van Buren Director $487,800 Mixed 18 Mar 2026
Nadine Baudot-Trajtenberg Director $487,800 Mixed 18 Mar 2026
Gruber Dafna Director $383,048 Mixed 18 Mar 2026
Troy Richardson Director $287,763 Mixed 18 Mar 2026
Michael D. Capellas Director $244,270 Mixed 18 Mar 2026

Recent insider transactions for Cellebrite DI Ltd.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
David Nicholas Gee CLBT Ordinary shares, par value NIS 0.00001 Sale -3.84% $74,477 $13.13 -5,673 142,032 21 May 2026 Direct
Marcus Jewell CLBT Ordinary shares, par value NIS 0.00001 Sale -2.8% $161,657 $12.77 -12,658 440,101 18 May 2026 Direct
David Nicholas Gee CLBT Ordinary shares, par value NIS 0.00001 Sale -0.15% $2,966 $13.01 -228 147,705 12 May 2026 Direct
Marcus Jewell CLBT Ordinary shares, par value NIS 0.00001 Sale -0.08% $4,983 $13.01 -383 452,759 12 May 2026 Direct
Shiven Ramji CLBT Ordinary shares, par value NIS 0.00001 Award 423,550 423,550 12 May 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .